Increased expression of the neuropeptide Y receptor Y1 gene in the medial amygdala of transgenic mice induced by long-term treatment with progesterone or allopregnanolone

Journal of Neurochemistry

Volumn 79, Issue 2, 2001, Pages 417-425

  Ferrara, Gianna ^a   Serra, Mariangela ^b   Zammaretti, Francesca ^a   Pisu, Maria Giuseppina ^b   Panzica, Giancarlo ^a   Biggio, Giovanni ^b   Eva, Carola ^a  

^a UNIVERSITY OF TURIN   (Italy)

^b UNIVERSITY OF CAGLIARI   (Italy)

Author keywords

Allopregnanolone; Amygdala; Neuroactive steroids; Progesterone; Transgenic mice; Y1 receptor for neuropeptide Y

Indexed keywords

3ALPHA HYDROXY 5ALPHA PREGNAN 20 ONE; 4 AMINOBUTYRIC ACID; BENZODIAZEPINE RECEPTOR; BETA GALACTOSIDASE; FINASTERIDE; NEUROPEPTIDE Y; NEUROPEPTIDE Y1 RECEPTOR; PROGESTERONE;

AMYGDALOID NUCLEUS; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; GENE; GENE EXPRESSION; HISTOCHEMISTRY; MOUSE; NONHUMAN; PRIORITY JOURNAL; TRANSGENIC MOUSE;

AMYGDALA; ANIMALS; CEREBRAL CORTEX; DESOXYCORTICOSTERONE; FEMALE; GENE EXPRESSION; MICE; MICE, TRANSGENIC; OSMOLAR CONCENTRATION; PREGNANOLONE; PROGESTERONE; RECEPTORS, NEUROPEPTIDE Y; TIME FACTORS;

ANIMALIA; MUS MUSCULUS;

EID: 0034775350     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.2001.00559.x     Document Type: Article

References (62)

1. T. The amygdala mediates the anxiolytic-like effect of the neurosteroid allopregnanolone in rat
2. Inhibition of rat α-reductases by finasteride: Evidence for isozyme differences in the mechanism of inhibition
3. Anticonvulsant profile of the progesterone metabolite 5α-pregnan-3α-ol-20-one
4. A receptor
5. Anxiolytic activity of NPY receptor agonists in the conflict test
6. Neuropeptide Y blocks anxiogenic-like behavioral action of corticotropin-releasing factor in an operant conflict test and elevated plus maze
7. Behavioral effects of neuropeptide Y receptor agonists in the elevated plus-maze and fear-potentiated startle procedures
8. A receptors
9. 35S]-TBPS binding in the brain of rats exposed to isoniazid, pentylenetetrazol or stress
10. Role of brain allopregnanolone in the plasticity of γ-aminobutyric acid type A receptor in rat brain during pregnancy and after delivery
11. A receptor plasticity by progesterone metabolites
12. A currents insensitive to benzodiazepine modulation in rat CA1 hippocampus
13. A receptor subunit peptide levels in rat cortex during chronic ethanol consumption and withdrawal
14. Tolerance to the behavioral actions of benzodiazepines
15. The estrus cycle, sensitivity to convulsants and the anticonvulsant effect of a neuroactive steroid
16. A receptor complex during pregnancy and after delivery in the rat brain
17. A receptor expression and during progesterone treatment and withdrawal
18. Anxiolytic metabolites of progesterone: Correlation with mood and performance measures following oral progesterone administration to healthy female volunteers
19. The neurosteroid 3α,5α-THP has antiseizure and possible neuroprotective effects in an animal model of epilepsy
20. Progesterone withdrawal decreases latency to and increases duration of electrified prod burial: A possible rat model of PMS anxiety
21. Neuroactive steroids, potential therapeutic use in neurological and psychiatric disorders
22. Inhibition of oxytocin receptor function by direct binding of progesterone
23. Neuropeptide Y localization in the rat amygdaloid complex
24. Ro 16-6028, a benzodiazepine receptor partial agonist, does not exhibit anticonvulsant tolerance in mice
25. Low plasma γ-aminobutyric acid levels during the late luteal phase of women with premenstrual dysphoric disorder
26. Antisense inhibition of neuropeptide Y (NPY)-Y1 receptor expression blocks the anxiolytic-like action of NPY in amygdala and paradoxically increases feeding
27. Anxiolytic-like action of neuropeptide Y: Mediation by Y1 receptors in amygdala, and dissociation from food intake effects
28. A receptor subunit mRNAs in the rat cortex
29. A receptor subunit expression in rat neocortex during tolerance to diazepam
30. Anxiogenic-like effect of the neuropeptide Y Y1 receptor antagonist BIBP3226: Antagonism with diazepam
31. 9-41 prevents anxiogenic-like effect of NPY Y1 receptor antagonist BIBP3226 in rats
32. Y1 and Y2 receptor selective neuropeptide Y analogues: Evidence for a Y1 receptor subclass
33. Anti-convulsant activity of neurosteroids: Correlation with γ-aminobutyric acid-evoked chloride current potentiation
34. A receptor function
35. Protein measurement with the Folin phenol reagent
36. Orally administered progesterone enhances sensitivity to triazolam in postmenopausal women
37. Coexistence of GABA and peptide immunoreactivity in non-pyramidal neurons of the basolateral amygdala
38. A receptor. Mechanism of action and physiological significance
39. Steroid hormone metabolites are barbiturate-like modulators of the GABA receptor
40. Progesterone withdrawal I: Proconvulsant effects
41. Progesterone withdrawal II. Insensitivity to the sedative effects of a benzodiazepine
42. The murine Y1 receptor 5′ upstream sequence directs cell-specific and developmentally regulated LacZ expression in transgenic mice CNS
43. 1 receptor gene expression in the medial amygdala of transgenic mice
44. 1 network in the medial amygdala: A neuroanatomical basis for their functional interaction
45. A receptor ct subunits after flurazepam treatment
46. Neuroactive steroids
47. Alprazolam dependence prevented by substituting with the β-carboline abecarnil
48. A receptors
49. Synthesis, metabolism and pharmacological activity of 3α-hydroxy-steroids which potentiate GABA-receptor-mediated chloride ion uptake in rat cerebral cortical synaptoneurosomes
50. Behaviorally selective effects of neuroactive steroids on plus-maze anxiety in mice
51. Neuroactive steroids, mechanisms of action and neuropsychopharmacological perspectives
52. 1 receptors mediate the anxiolytic-like actions of neuropeptide Y in the social interaction test
53. Long-term treatment with abecarnil fails to induce tolerance in mice
54. A receptor function in rat brain
55. A receptor α4 subunit suppression prevents withdrawal properties of an endogenous steroid
56. A receptor α4 subunit in association with increased anxiety
57. Long-term treatment with abecarnil does not induce diazepam-like dependence in mice
58. Down-regulation of the GABA receptor subunit mRNA levels in mammalian cultured cortical neurons following chronic neurosteroid treatment
59. Anxiolytic activity of the progesterone metabolite 5α-pregnan-3α-ol-20-one
60. Benzodiazepines, use, abuse and consequences
61. Reduced expression of γ-aminobutyric acid type A/benzodiazepine receptor γ2 and α5 subunit mRNAs in brain regions of flurazepam-treated rats